These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 12474879

  • 21. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 Feb 08; 67(27):5942-3. PubMed ID: 11837282
    [Abstract] [Full Text] [Related]

  • 22. Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment.
    Fed Regist; 2000 Jan 03; 65(1):7-9. PubMed ID: 11010625
    [Abstract] [Full Text] [Related]

  • 23. Antidiarrheal drug products for over-the-counter human use; amendment of final monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 May 12; 69(92):26301-2. PubMed ID: 15141675
    [Abstract] [Full Text] [Related]

  • 24. Dandruff, seborrheic dermatitis, and psoriasis drug products containing coal tar and menthol for over-the-counter human use; amendment to the monograph. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Mar 06; 72(43):9849-52. PubMed ID: 17447341
    [Abstract] [Full Text] [Related]

  • 25. Topical antifungal drug products for over-the-counter human use; amendment of final monograph. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Aug 29; 65(168):52302-5. PubMed ID: 11067736
    [Abstract] [Full Text] [Related]

  • 26. Skin protectant drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Dec 09; 68(236):68509-11. PubMed ID: 14664244
    [Abstract] [Full Text] [Related]

  • 27. Astringent drug products that produce aluminum acetate; skin protectant drug products for over-the-counter human use; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS.
    Fed Regist; 2009 Mar 06; 74(43):9759-65. PubMed ID: 19418638
    [Abstract] [Full Text] [Related]

  • 28. Drug labeling; sodium labeling for over-the-counter drugs. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2004 Nov 29; 69(228):69278-80. PubMed ID: 15570675
    [Abstract] [Full Text] [Related]

  • 29. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of final monograph for over-the-counter nasal decongestant drug products. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2005 Oct 11; 70(195):58974-7. PubMed ID: 16217879
    [Abstract] [Full Text] [Related]

  • 30. Classification of benzoyl peroxide as safe and effective and revision of labeling to drug facts format; topical acne drug products for over-the-counter human use; final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2010 Mar 04; 75(42):9767-77. PubMed ID: 20383916
    [Abstract] [Full Text] [Related]

  • 31. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use; delay of compliance dates. Final rule; delay of compliance dates; request for comments.
    Food and Drug Administration, HHS.
    Fed Regist; 2012 May 11; 77(92):27591-3. PubMed ID: 22606729
    [Abstract] [Full Text] [Related]

  • 32. Over-the-counter drug products containing colloidal silver ingredients or silver salts. Department of Health and Human Services (HHS), Public Health Service (PHS), Food and Drug Administration (FDA). Final rule.
    Fed Regist; 1999 Aug 17; 64(158):44653-8. PubMed ID: 10558603
    [Abstract] [Full Text] [Related]

  • 33. Ophthalmic drug products for over-the-counter human use; final monograph; technical amendment. Final rule; technical amendment.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 Feb 19; 68(33):7919-21. PubMed ID: 12593411
    [Abstract] [Full Text] [Related]

  • 34. Laxative drug products for over-the-counter human use; psyllium ingredients in granular dosage forms. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2007 Mar 29; 72(60):14669-74. PubMed ID: 17450664
    [Abstract] [Full Text] [Related]

  • 35. Cold, cough, allergy, bronchodilator, and antiasthmatic drug products for over-the-counter human use; amendment of monograph for OTC nasal decongestant drug products. Final rule.
    Fed Regist; 2006 Aug 01; 71(147):83358[sic., should be 43358]-63. PubMed ID: 16892519
    [Abstract] [Full Text] [Related]

  • 36. Status of certain additional over-the-counter drug category II and III active ingredients. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2002 May 09; 67(90):31125-7. PubMed ID: 12001972
    [Abstract] [Full Text] [Related]

  • 37. Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use. Final rule.
    Food and Drug Adminnistration, HHS.
    Fed Regist; 2016 Sep 06; 81(172):61106-30. PubMed ID: 27632802
    [Abstract] [Full Text] [Related]

  • 38. Ingrown toenail relief drug products for over-the-counter human use. Final rule.
    Food and Drug Administration, HHS.
    Fed Regist; 2003 May 07; 68(88):24347-9. PubMed ID: 12737160
    [Abstract] [Full Text] [Related]

  • 39. Laxative drug products for over-the-counter human use. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 1999 Jan 29; 64(19):4535-40. PubMed ID: 10557608
    [Abstract] [Full Text] [Related]

  • 40. Ophthalmic drug products for over-the-counter human use; proposed amendment of final monograph--FDA. Proposed rule.
    Fed Regist; 1998 Feb 23; 63(35):8888-90. PubMed ID: 10177740
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.